$2.03 +0.10 (5.18%) Antares Pharma Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 2.03
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.10 (5.18%)
Prev Close: 1.93
Open: 1.91
Bid: 2.03
Ask: 2.04
  1. No results found.
  1. Mid-Afternoon Market Update: Crude Oil Climbs 6%; Sprint Shares Gain Following Strong Q3 Earnings

    Benzinga | Jan. 26, 2016 | 14:40PM EST
  2. Antares Pharma Announces Update to Quickshot Testosterone Clinical Program

    Benzinga | Oct. 30, 2015 | 06:11AM EST
  3. Benzinga's Top Initiations

    Benzinga | May. 18, 2015 | 08:22AM EST
  4. Piper Jaffray Initiates Antares Pharma With Overweight

    Benzinga | May. 18, 2015 | 07:56AM EST
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  6. Morning Market Losers

    Benzinga | Jan. 13, 2015 | 10:01AM EST
  7. Tuesday Morning Movers: ChannelAdvisor Plummets

    Benzinga | Jan. 13, 2015 | 09:29AM EST
  8. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  9. Antares Pharma Announces Additional Patent Coverage for OTREXUP

    Benzinga | Apr. 16, 2014 | 06:21AM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 11, 2014 | 09:17AM EST
  11. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 03:51AM EST
  12. Antares Pharma Announces Availability of OTREXUP Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis in Children

    Benzinga | Jan. 15, 2014 | 07:09AM EST
  13. Antares Pharma Awarded Additional U.S. Patent Protection for OTREXUP™

    Benzinga | Nov. 26, 2013 | 07:05AM EST
  14. Antares Pharma Announces Issuance of Patent for VIBEX Device Platform

    Benzinga | Oct. 25, 2013 | 06:03AM EST
  15. Mid-Afternoon Market Update: Market Holds Awaiting Public Address From Congressional Leaders

    Benzinga | Oct. 14, 2013 | 14:50PM EST
Trading Center